In our study, one single administration of CTX + ACT/IS, tested as a prophylactic strategy in tumor-free mice, caused a significant delay in the appearance of spontaneous tumor masses development with respect to untreated HER-2/neu mice. Here, ERBB2 is linked to neoplasm.